Abstract
Effects of protease inhibitors and absorption enhancers on the absorption of salmon calcitonin (sCT) were evaluated after intratracheal coadministration to rats using the plasma Ca level as an index. Remarkable absorption enhancement could be attained with unsaturated fatty acids such as oleic acid and polyoxyethylene oleyl ether (absorption enhancers) and with chymostatin, bacitracin, potato carboxypeptidase inhibitor and phosphoramidon (protease inhibitors). sCT degrading enzymes had four times higher activity per total protein in membrane fraction of lung homogenates than the activity in cytosol fraction. These enzymes are thought to be serine proteases and metalloenzymes from the in vitro action profile of protease inhibitors. A good correlation between the in vitro activity of protease inhibitors and the in vivo enhancing effect on sCT activity suggested that membrane enzymes are responsible for the inactivation of sCT. Metabolic degradation and low permeability of sCT may be possible barriers to the absorption of sCT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. S. Patton and R. M. Platz. (D) Routes of delivery: Case studies, (2) Pulmonary delivery of peptides and proteins for systemic action. Adv. Drug Deliv. Rev. 8:179–196 (1992).
L. L. Wearley. Recent progress in protein and peptide delivery by noninvasive routes. Crit. Rev. Ther. Drug Carrier Syst. 8(4):331–394 (1991).
S. J. Enna and L. S. Schanker. Absorption of saccharides and urea from the rat lung. Am. J. Physiol. 222(2):409–414 (1972).
K. Okumura, S. Iwakawa, T. Yoshida, T. Seki, and F. Komada. Intratracheal delivery of insulin, Absorption from solution and aerosol by rat lung. Int. J. Pharm. 88:63–73 (1992).
F. L. Liu, D. O. Kildsig and A. K. Mitra. Pulmonary biotransformation of insulin in rat and rabbit. Life Science 51, 1683–1689 (1992).
M. N. Gillespie, J. W. Krechniak, P. A. Crooks, R. J. Altiere, and J. W. Olson. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs. J. Pharm. Exp. Ther. 232(3):675–681 (1985).
N. P. Stimler-Gerard. Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung. J. Clin. Invest. 79:1819–1825 (1987).
M. Hanson, G. Gazdick, J. Gahill, and M. Augustine. Intranasal delivery of the peptide, salmon calcitonin. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Press, London, 1986, pp. 233–242.
Y. Nakada, M. Miyake, and N. Awata. Some factors affecting the vaginal absorption of human calcitonin in rats. Int. J. Pharm. 89:169–175 (1993).
V. H. L. Lee. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Controlled Rel. 13:213–223 (1990).
S. Hirai, T. Yashiki, and H. Mima. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9:173–184 (1981).
R. W. Niven and P. R. Byron. Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorption of fluorescein. Pharm. Res. 7(1):8–13 (1990).
I. C. Ehrhard and W. F. Hofman. Oleic acid dose-related edema in isolated canine lung perfused at constant pressure. J. Appl. Physiol.: Respirat. Environ. Exer. Phys. 50(6):1115–1120 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobayashi, S., Kondo, S. & Juni, K. Study on Pulmonary Delivery of Salmon Calcitonin in Rats: Effects of Protease Inhibitors and Absorption Enhancers. Pharm Res 11, 1239–1243 (1994). https://doi.org/10.1023/A:1018926007902
Issue Date:
DOI: https://doi.org/10.1023/A:1018926007902